Xin Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xin Hu has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Tong Su
Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China
8 shared publications Haofeng Xiong
Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, No.87 Xiangya Road, Changsha, 410008, Hunan, China
3 shared publications- Haofeng Xiong
Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China
3 shared publications - Kun Xia
Correspondence to: Prof. Kun Xia, The Key Laboratory of Pediatric Rare Diseases of the Ministry of Education, Central South University, Changsha & University of South China, Hengyang 421001, Hunan, China
3 shared publications Can Wang
Department of Oral and Maxillofacial Surgery Center of Stomatology Xiangya Hospital Central South University Changsha China
2 shared publications- Danni Huang
Department of Oral and Maxillofacial Surgery Center of Stomatology Xiangya Hospital Central South University Changsha China
2 shared publications
Latest Publications
- Open Access
- 1 March 2026
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 19, 1-9
Prognosis Impact of Betel Nut on Oral Squamous Cell Carcinoma: A Population-Based Study
The prognostic impact of betel nut on oral squamous cell carcinoma (OSCC) remains controversial. This study aimed to determine whether betel nut chewing is an independent prognostic factor in patients treated with standardized surgery. This retrospective population-based cohort study enrolled 1113 patients with primary OSCC, including 922 betel nut chewers and 191 non-chewers. All patients underwent standardized surgical treatment. The prognostic impact of betel nut chewing was evaluated by returning to all patients and comparing the disease-free survival times between the two groups. The Chi-square test was used to explore the clinical characteristics associated with betel nut chewing. Kaplan-Meier survival analysis, univariable Cox regression, and multivariable Cox regression analyses were used to investigate the prognostic impact of betel nut. No significant difference was observed in the disease-free survival time between chewers and non-chewers in either the overall group or subgroup analyses. Univariable Cox regression analysis indicated that betel nut use was not a prognostic factor. After adjusting for potential confounders, multivariable Cox regression confirmed that cervical lymph node metastasis, clinical stage, and pathological grade were independent risk factors for prognosis, whereas betel nut use had no significant impact on prognosis. These findings suggest that the prognosis of OSCC is dictated by the biological stage of the tumor rather than betel nut use. This allows clinicians to develop more objective, precise treatment plans for OSCC patients.
- 1 March 2026
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 19, 1-9
Open AccessPrognosis Impact of Betel Nut on Oral Squamous Cell Carcinoma: A Population-Based Study
The prognostic impact of betel nut on oral squamous cell carcinoma (OSCC) remains controversial. This study aimed to determine whether betel nut chewing is an independent prognostic factor in patients treated with standardized surgery. This retrospective population-based cohort study enrolled 1113 patients with primary OSCC, including 922 betel nut chewers and 191 non-chewers. All patients underwent standardized surgical treatment. The prognostic impact of betel nut chewing was evaluated by returning to all patients and comparing the disease-free survival times between the two groups. The Chi-square test was used to explore the clinical characteristics associated with betel nut chewing. Kaplan-Meier survival analysis, univariable Cox regression, and multivariable Cox regression analyses were used to investigate the prognostic impact of betel nut. No significant difference was observed in the disease-free survival time between chewers and non-chewers in either the overall group or subgroup analyses. Univariable Cox regression analysis indicated that betel nut use was not a prognostic factor. After adjusting for potential confounders, multivariable Cox regression confirmed that cervical lymph node metastasis, clinical stage, and pathological grade were independent risk factors for prognosis, whereas betel nut use had no significant impact on prognosis. These findings suggest that the prognosis of OSCC is dictated by the biological stage of the tumor rather than betel nut use. This allows clinicians to develop more objective, precise treatment plans for OSCC patients.
- Open Access
- 19 July 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1212
The key target and role of betel nut in oral squamous cell carcinoma
Betel nut consumption is closely related to oral cancer. This study aimed to explore the crucial target and role of betel nut in oral cancer. We used RNA sequencing and protein-protein interaction networks to screen the key target of betel nut in oral cancer. Enrichment analysis was used to explore the role of betel nut. Immunohistochemical analysis was used to identify the expression trend of the key target, and survival analysis was used to explore the prognostic value of the key target. The animal model of oral cancer was used to verify the key target of betel nut. Firstly, 1108 genes were differentially expressed in oral cancer under the influence of betel nut, which may be involved in "metabolic pathways." Moreover, TP53 was the key target of betel nut and was upregulated, resulting in poor prognosis in patients with oral cancer. Finally, the differential expression and role of TP53 in oral cancer with betel nut were validated by human and animal samples. In conclusion, we found that TP53 upregulation may be the crucial biological phenomenon in the oral cancer with betel nut, indicating that TP53 may be the key target of betel nut in oral cancer.
- 19 July 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1212
Open AccessThe key target and role of betel nut in oral squamous cell carcinoma
Betel nut consumption is closely related to oral cancer. This study aimed to explore the crucial target and role of betel nut in oral cancer. We used RNA sequencing and protein-protein interaction networks to screen the key target of betel nut in oral cancer. Enrichment analysis was used to explore the role of betel nut. Immunohistochemical analysis was used to identify the expression trend of the key target, and survival analysis was used to explore the prognostic value of the key target. The animal model of oral cancer was used to verify the key target of betel nut. Firstly, 1108 genes were differentially expressed in oral cancer under the influence of betel nut, which may be involved in "metabolic pathways." Moreover, TP53 was the key target of betel nut and was upregulated, resulting in poor prognosis in patients with oral cancer. Finally, the differential expression and role of TP53 in oral cancer with betel nut were validated by human and animal samples. In conclusion, we found that TP53 upregulation may be the crucial biological phenomenon in the oral cancer with betel nut, indicating that TP53 may be the key target of betel nut in oral cancer.
- Open Access
- 23 August 2024
- Published by Wiley in Cancer Medicine
- Vol. 13 (16) , e70076
XPO1 serves as a prognostic marker involving AKT/MAPK/TGFBR1 pathway in OSCC
Background: Exportin 1 (XPO1) is a nuclear export protein that facilitates the transportation of various substances. XPO1 promotes tumor development as a poor prognostic factor in a variety of tumors and is a therapeutic target for screening inhibitors. However, the role of XPO1 in oral squamous cell carcinoma (OSCC) has yet to be determined.Methods: The expression patterns of XPO1 mRNA in OSCC were investigated using bioinformatics tools, and the expression levels of XPO1 protein in OSCC specimens were confirmed by immunohistochemical assays. Survival analysis was conducted to evaluate the impact of XPO1 on prognosis. GO and KEGG enrichment analyses were utilized to uncover the signaling pathways mediated by XPO1. Additionally, we examined the association between XPO1 and AKT/MAPK/TGFBR1 and immune infiltration.Results: XPO1 mRNA and protein expression levels were significantly enhanced in OSCC and associated with OSCC severity. Enhanced XPO1 expression was indicative of poor survival. Functional analysis showed that XPO1 mediated pathways associated with cell cycle and DNA replication and reduced immune infiltration in OSCC. Additionally, XPO1 mRNA and protein expression levels had significant positive relationships with AKT/MAPK/TGFBR1.Conclusions: XPO1, as a marker of poor prognosis in OSCC, can promote OSCC through AKT/MAPK/TGFBR1.
- 23 August 2024
- Published by Wiley in Cancer Medicine
- Vol. 13 (16) , e70076
Open AccessXPO1 serves as a prognostic marker involving AKT/MAPK/TGFBR1 pathway in OSCC
Background: Exportin 1 (XPO1) is a nuclear export protein that facilitates the transportation of various substances. XPO1 promotes tumor development as a poor prognostic factor in a variety of tumors and is a therapeutic target for screening inhibitors. However, the role of XPO1 in oral squamous cell carcinoma (OSCC) has yet to be determined.Methods: The expression patterns of XPO1 mRNA in OSCC were investigated using bioinformatics tools, and the expression levels of XPO1 protein in OSCC specimens were confirmed by immunohistochemical assays. Survival analysis was conducted to evaluate the impact of XPO1 on prognosis. GO and KEGG enrichment analyses were utilized to uncover the signaling pathways mediated by XPO1. Additionally, we examined the association between XPO1 and AKT/MAPK/TGFBR1 and immune infiltration.Results: XPO1 mRNA and protein expression levels were significantly enhanced in OSCC and associated with OSCC severity. Enhanced XPO1 expression was indicative of poor survival. Functional analysis showed that XPO1 mediated pathways associated with cell cycle and DNA replication and reduced immune infiltration in OSCC. Additionally, XPO1 mRNA and protein expression levels had significant positive relationships with AKT/MAPK/TGFBR1.Conclusions: XPO1, as a marker of poor prognosis in OSCC, can promote OSCC through AKT/MAPK/TGFBR1.
- Open Access
- 1 January 2022
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 15, 141-152
Tumor-Infiltrating CD4+ Central Memory T Cells Correlated with Favorable Prognosis in Oral Squamous Cell Carcinoma
Objective: Oral squamous cell carcinoma (OSCC) is the most frequent oral malignancy with a poor prognosis, in which tumor-infiltrating immune cells may play a critical role. Therefore, our study aims to screen potential immune cells and immune-related genes for predicting OSCC prognosis. Methods: A total of 310 OSCC patients with full transcriptional data and clinical characteristics were extracted from the TCGA database. Then, we obtained their abundance of tumor-infiltrating immune cells on TIMER 2.0 and analyzed them using xCell method. Univariate and multivariate Cox regressions were applied successively to identify the immune cells associated with overall survival of OSCC patients. Furthermore, we screened the prognostic genes that related to the identified immune cells and validated their expressions by immunohistochemistry. Results: CD4+ central memory T (TCM) cell was recognized as the sole independent immune cell correlated with OSCC prognosis (p = 0.0085). A novel nomogram based on CD4+ TCM cell abundance was established for predicting the prognosis of OSCC patients, with calibration plots showing good performance for 1-, 3-, 5-year overall survival. Thirty-four related prognostic genes were screened according to the differential abundance of CD4+ TCM cell infiltration. In immunohistochemistry analysis, DEFB1 showed a significant positive relationship with the density of CD4+ TCM cells (p = 0.0075). Conclusion: CD4+ central memory T cell was proposed as an independent prognostic biomarker for OSCC patients. DEFB1 might positively regulate the abundance of tumor-infiltrating CD4+ TCM cells, thus improving OSCC prognosis. Our findings may provide a new insight into better prognosis prediction and precise medicine for OSCC.
- 1 January 2022
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 15, 141-152
Open AccessTumor-Infiltrating CD4+ Central Memory T Cells Correlated with Favorable Prognosis in Oral Squamous Cell Carcinoma
Objective: Oral squamous cell carcinoma (OSCC) is the most frequent oral malignancy with a poor prognosis, in which tumor-infiltrating immune cells may play a critical role. Therefore, our study aims to screen potential immune cells and immune-related genes for predicting OSCC prognosis. Methods: A total of 310 OSCC patients with full transcriptional data and clinical characteristics were extracted from the TCGA database. Then, we obtained their abundance of tumor-infiltrating immune cells on TIMER 2.0 and analyzed them using xCell method. Univariate and multivariate Cox regressions were applied successively to identify the immune cells associated with overall survival of OSCC patients. Furthermore, we screened the prognostic genes that related to the identified immune cells and validated their expressions by immunohistochemistry. Results: CD4+ central memory T (TCM) cell was recognized as the sole independent immune cell correlated with OSCC prognosis (p = 0.0085). A novel nomogram based on CD4+ TCM cell abundance was established for predicting the prognosis of OSCC patients, with calibration plots showing good performance for 1-, 3-, 5-year overall survival. Thirty-four related prognostic genes were screened according to the differential abundance of CD4+ TCM cell infiltration. In immunohistochemistry analysis, DEFB1 showed a significant positive relationship with the density of CD4+ TCM cells (p = 0.0075). Conclusion: CD4+ central memory T cell was proposed as an independent prognostic biomarker for OSCC patients. DEFB1 might positively regulate the abundance of tumor-infiltrating CD4+ TCM cells, thus improving OSCC prognosis. Our findings may provide a new insight into better prognosis prediction and precise medicine for OSCC.
- 11 March 2021
- Published by Wiley in Oral Diseases
- Vol. 28 (7) , 1811-1815
Primary poorly differentiated neuroendocrine carcinoma of the oral cavity
- 11 March 2021
- Published by Wiley in Oral Diseases
- Vol. 28 (7) , 1811-1815
Primary poorly differentiated neuroendocrine carcinoma of the oral cavity
- 1 April 2020
- Published by Elsevier in Archives of Oral Biology
- Vol. 112, 104687
Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma
- 1 April 2020
- Published by Elsevier in Archives of Oral Biology
- Vol. 112, 104687
Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Brazilian Oral Research
- Vol. 34, e052
DEC1: a potential biomarker of malignant transformation in oral leukoplakia
The purpose of this study was to analyze the differential expression of DEC1 in oral normal mucosa (NM), oral leukoplakia (OLK) and oral squamous cell carcinoma (OSCC). Surgically excised specimens from patients with OLK (n = 47), OSCC (n = 30) and oral normal mucosa (n=11) were immunostained for DEC1. The expression of DEC1 protein was evaluated, and its association with the clinicopathological features was analyzed. The expression of DEC1 in NM, OLK and OSCC tissues increased in turn, and significant differences were observed among the groups (P < 0.0001). In terms of the association between DEC1 expression and epithelial dysplasia, DEC1 expression was lower in hyperkeratosis without dysplasia (H-OLK) than in OLK with moderate to severe dysplasia (S-OLK), and these differences were significant (p < 0.05). The expression of DEC1 in OSCC with OLK was significantly higher than that in OSCC without OLK (p < 0.01). Therefore, DEC1 could be a potential biomarker of malignant transformation in the carcinogenesis of OSCC, which may provide a new research direction for the transformation of oral potentially malignant disorders (OPMDs) into OSCC.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Brazilian Oral Research
- Vol. 34, e052
Open AccessDEC1: a potential biomarker of malignant transformation in oral leukoplakia
The purpose of this study was to analyze the differential expression of DEC1 in oral normal mucosa (NM), oral leukoplakia (OLK) and oral squamous cell carcinoma (OSCC). Surgically excised specimens from patients with OLK (n = 47), OSCC (n = 30) and oral normal mucosa (n=11) were immunostained for DEC1. The expression of DEC1 protein was evaluated, and its association with the clinicopathological features was analyzed. The expression of DEC1 in NM, OLK and OSCC tissues increased in turn, and significant differences were observed among the groups (P < 0.0001). In terms of the association between DEC1 expression and epithelial dysplasia, DEC1 expression was lower in hyperkeratosis without dysplasia (H-OLK) than in OLK with moderate to severe dysplasia (S-OLK), and these differences were significant (p < 0.05). The expression of DEC1 in OSCC with OLK was significantly higher than that in OSCC without OLK (p < 0.01). Therefore, DEC1 could be a potential biomarker of malignant transformation in the carcinogenesis of OSCC, which may provide a new research direction for the transformation of oral potentially malignant disorders (OPMDs) into OSCC.
- 2 February 2018
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 126 (1) , 48-53
Differential expression of organic cation transporter 3 in oral submucous fibrosis–associated buccal squamous cell carcinoma
- 2 February 2018
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 126 (1) , 48-53
Differential expression of organic cation transporter 3 in oral submucous fibrosis–associated buccal squamous cell carcinoma